Contents

Business Areas

The best partner for precision medicine

Genomic Analysis
(GenoLifeCare™)

Invites BioCore's Life Science Business Unit provides testing services
for disease prediction, diagnosis, and genetic identification through
chromosome/base sequence analysis, as well as total healthcare solutions
for the entire life cycle.

In addition, we have obtained certification from the College of American Pathologists (CAP) for Next-Generation Sequencing (NGS)
and Microarray clinical testing, and possess global-level genome analysis capabilities, producing highly reliable test results.
We consistently receive the highest rating in proficiency testing (quality evaluation) for genetic testing agencies every year.

  • GenoLifeCare™
    • GenoCare
    • GenoCheck
    • GenoCoach
    • Genomic Analysis
GenoCare
(Predictive Testing)

Total Healthcare Solution Service

We provide a total healthcare solution for the entire lifespan,
from preparing for pregnancy to childbirth, infancy, and adulthood.

Inspection Type
Disease Susceptibility Test

Our service provides individual genetic testing that analyzes the genetic risk through major cancer/disease-related specific gene testing
and predicts the risk of cancer/disease occurrence.
This refers to a test to determine whether or not a person has a known genetic variation that is associated with a certain disease,
even if they currently have no symptoms, as a preventative measure.

The advantage of predictive analysis is that molecular genetic testing is possible before the onset of the disease, which can help prevent,
early diagnose, treat, and manage the disease in conjunction with other screening methods, reducing the incidence
and mortality rates of the disease.

GenoCare VIP 50 Types of Susceptibility Test
  • Cancer 16 types - Gastric cancer, colorectal cancer, thyroid cancer, lung cancer, liver cancer, pancreatic cancer, bladder cancer, gallbladder and biliary tract cancer, esophageal cancer, skin cancer, acute leukemia, prostate cancer, breast cancer, cervical cancer, endometrial cancer, ovarian cancer
  • Diseases Ⅰ 24 types - Stroke, myocardial infarction, hyperlipidemia, type 2 diabetes, coronary artery disease, dementia, osteoporosis, rheumatoid arthritis, osteoarthritis, hypertension, cerebral hemorrhage, osteoarthritis, asthma, pneumonia, obesity, glaucoma, gout, migraine, chronic obstructive pulmonary disease, Parkinson's disease, macular degeneration, periodontal disease, depression, alopecia
  • Diseases Ⅱ 10 types - Micro dust inflammation response, allergic rhinitis, sinusitis, otitis media, atopic dermatitis, psoriasis, acne, allergic conjunctivitis, muscle strength, ADHD.
GenoCare Premium 40 types of susceptibility test
  • Cancers 16 types - stomach cancer, colorectal cancer, thyroid cancer, lung cancer, liver cancer, pancreatic cancer, bladder cancer, gallbladder and biliary tract cancer, esophageal cancer, skin cancer, acute leukemia, prostate cancer, breast cancer, cervical cancer, endometrial cancer, ovarian cancer
  • Diseases 24 types - stroke, myocardial infarction, hyperlipidemia, type 2 diabetes, coronary artery disease, dementia, osteoporosis, rheumatoid arthritis, osteoarthritis, hypertension, cerebral hemorrhage, osteoarthritis, asthma, pneumonia, obesity, glaucoma, gout, migraine, chronic obstructive pulmonary disease (COPD), Parkinson's disease, macular degeneration, periodontal disease, depression, alopecia
GenoCare Special 30 types of susceptibility test
  • Cancers 12 types - Stomach cancer, colorectal cancer, thyroid cancer, lung cancer, liver cancer, pancreatic cancer, bladder cancer, acute leukemia, prostate cancer, breast cancer, cervical cancer, ovarian cancer
  • Diseases 18 types - Stroke, myocardial infarction, hyperlipidemia, type 2 diabetes, coronary artery disease, dementia, osteoporosis, rheumatoid arthritis, hypertension, cerebral hemorrhage, asthma, pneumonia, glaucoma, gout, Parkinson's disease, periodontal disease, depression, hair loss
GenoCare Special 16 types of susceptibility test
  • Cancer 9 types - Stomach cancer, colorectal cancer, thyroid cancer, lung cancer, liver cancer, pancreatic cancer, bladder cancer, prostate cancer, breast cancer
  • Diseases 7 types - Stroke, hyperlipidemia, type 2 diabetes, coronary artery disease, dementia, hypertension, Parkinson's disease.
GenoCare Basic 7 types of susceptibility test
  • Cancer 7 types - gastric cancer, colorectal cancer, thyroid cancer, lung cancer, liver cancer, prostate cancer, breast cancer
GenoCare General Disease 5 types of susceptibility test
  • Diseases 5 types - stroke, type 2 diabetes, coronary artery disease, dementia, Parkinson's disease
GenoCare Circulatory System 5 types of susceptibility test
  • Diseases 5 types - hyperlipidemia, hypertension, cerebral hemorrhage, myocardial infarction, migraine
GenoCare KIDS 18 types of susceptibility test
  • Diseases 18 types - fine dust inflammation response, allergic rhinitis, abscess, otitis media, atopic dermatitis, psoriasis, acne, allergic conjunctivitis, muscle strength, ADHD, asthma, pneumonia, type 1 diabetes, type 2 diabetes, appetite, obesity, body fat breakdown rate, depression
Anticancer drug
susceptibility test

This test recommends the optimal anticancer drug by comparing the degree of cancer cell death through tissue culture based on Adenosine TriPhosphate and chemical reactions with anticancer drugs.

Workflow
01. Consulting

Consultation on types of tests, test costs, and how to request tests
(conducted through affiliated medical institutions)

02. Test Request

Sample collection and preparation of the test request and genetic testing consent form
(performed in collaboration with a specialized medical institution)

03. Test Implementation

Performance of DNA extraction and genetic testing

04. Results Report

Delivery of test results
(to be received from a linked specialized medical institution)

GenoCheck
(Diagnostic Test)
Test Request Form Test Consent Form Test Request Form(NIPT/CMA)

personalized genetic testing services

We aim to provide reliable test results to patients and doctors through personalized genetic testing services.
By analyzing the genome and identifying relevant genes, we can produce accurate diagnostic test results.

Inspection type
CMA(Chromosomal Microarray Analysis)

We are striving to provide individualized precision medical services by analyzing results that can be utilized for disease diagnosis,
treatment efficacy determination, and prognosis prediction from all specimens derived from the human body.

NBS(NewBorn Screening)

The rare disease test for newborns is a technology for providing personalized medical and healthcare services based on comprehensive
analysis of an individual's genetic information, clinical information, and lifestyle information in precision medicine.

DES(Diagnostic Exome Sequencing)

NGS testing enables personalized precision medical analysis and diagnosis by analyzing genetic variations related to diseases on an individual basis.
This test utilizes NGS analysis to identify the cause of rare genetic diseases by analyzing the Exome region, which is capable of
synthesizing proteins from human genes.
Through individual genome analysis, we predict the risk of developing diseases that may be caused by genetic factors and provide personalized
treatment information.

Non-invasive Prenatal Testing (NITS)

This is a non-invasive prenatal test that uses the Droplet Digital PCR technology to analyze up to three genetic information per well
and employs the Oil PCR method.

NIPT (Non Invasive Prenatal Test)

NIPT is a screening test for prenatal abnormalities that mothers who have passed 10 weeks of pregnancy can receive,
and it checks for fetal chromosomal abnormalities through the mother's blood.
It is a test to find out the risk of chromosomal abnormalities such as Down syndrome, Edward syndrome and Patau syndrome by collecting blood
from pregnant women and using next-generation sequencing (NGS) using fetal DNA that is present in small amounts in the mother's blood.
This allows early detection of abnormalities in the fetus and proper treatment.

GLC Chromosomal NGS (Cytogenetics)

It analyzes individual genome sequencing using next-generation sequencing (NGS) technology.
This makes it possible to more accurately and comprehensively examine copy number changes for the entire genome, thereby increasing
the diagnosis rate compared to conventional nucleoid methods.
This can help patients diagnose and treat them by reducing errors in tests and providing more accurate tests and interpretations.

GLC NBS (NewBornScreening)

Newborn Screening is a very effective test that can identify genetic disorders such as developmental disorders, mental retardation and behavioral disorders in newborns caused by chromosomal abnormalities (chromosome number abnormalities, some structural abnormalities) before expression.
Newborn genetic testing using next-generation sequencing (NGS) can accurately and accurately detect microscopic variations by examining
the entire chromosome at once. Early detection of these congenital diseases through NGS neonatal genetic testing can provide appropriate
treatment and effectively respond to symptom relief.

GLC NMD Gene test (Newborn Metabolic Abnormal, Deafness Genetic Test)

The neonatal screening test is a test conducted on newborns in order to detect and treat diseases early.
The neonatal congenital metabolic abnormalities test examines the hereditary metabolic diseases in which substances that need to be broken
down by enzymes accumulate in the body during metabolism in the body, resulting in human dysfunction. It also tests for congenital hearing
loss that occurs from birth. Inborn hearing loss occurs due to maternal infections such as rubella, CMV, herpes simplex virus,
premature babies, underweight babies, injuries during childbirth, drug alcohol consumed by the mother during pregnancy, complications related to
the Rh factor in the blood, jaundice, maternal diabetes, pregnancy poisoning during pregnancy, and oxygen deficiency.
The GLC NMD Gene test
uses next-generation sequencing technology to analyze the nucleotide sequence of the gene mutation site associated with the disease.

Workflow
01. Consulting

Consultation on types of tests, test costs, and how to request tests
(conducted through affiliated medical institutions)

02. Test Request

Sample collection and preparation of the test request and genetic testing consent form
(performed in collaboration with a specialized medical institution)

03. Test Implementation

Performance of DNA extraction and genetic testing

04. Results Report

Delivery of test results
(to be received from a linked specialized medical institution)

GenoCoach(DTC)

GenoCoach is a DTC (Direct-to-Consumer) genetic testing service provided by Invites BioCore

Our healthcare service, GenoCoach, utilizes an individual's DNA to provide an analysis of
their genetic characteristics through the most scientifically selected biomarkers.

Get your "Instruction Manual for Your Body" from the comfort of your own home.
Genes are the 'Instruction Manual for Your Body' that record innate information.
A difference of about 0.1% in genes creates genetic diversity among people and creates unique physiques
that are different from all others.

Go to GenoCoach DTC testing
Genomic Analysis

Best Genetic Analysis Service

Based on extensive experience in various genome experiments and bioinformatics analyses,
we provide the best genome analysis service by incorporating the latest genome technologies.

Analysis Service
Microarray Analysis Service

DNA MICROARRAY is a technique for analyzing differences in gene expression variations by aligning hundreds to thousands of
DNA on a slide glass that has been immobilized, and combining fluorescent materials with DNA or RNA extracted from the sample to measure the degree of binding to the DNA immobilized on the slide glass.

Fields of Application
  • GENE EXPRESSION
  • RNA EXPRESSION
  • CYTOGENETICS
    (CNV/ACGH)
  • METHYLATION/
    CHIP-ON-CHIP
Workflow
Consultation and Request
  • Selection of arrays and applications that fit the research purpose.
SAMPLE Q.C.
  • NANODROP
  • BIOANALYZER
  • TAPESTATION
  • EPOCH
  • Enable QUBIT
MICROARRAY EXPERIMENT
  • AFFYMETRIX ARRAY
  • AGILENT ARRAY
  • THERMOFISHER SNP ARRAY
DATA ANALYSIS
  • GENESPRING GX-PA V13.1.1
  • EXPRESSION CONSOLE
  • TRANSCRIPTOME ANALYSIS CONSOLE
  • CHROMOSOME ANALYSIS SUITE
  • AGILENT GENOMIC WORKBENCH
Next-generation Sequencing
(NGS) service

Next Generation Sequencing (NGS) is an analysis technology that breaks down a genome into countless pieces and reads each piece simultaneously.
The obtained data is then combined using bioinformatic techniques to rapidly decipher vast amounts of genetic information.

Fields of Application
  • Targeted Sequencing
  • Aneuploidy Analysis
  • Metagenome
    Sequencing
  • Viral Whole Genome
    Sequencing
  • Whole Genome
    Seqeuncing
  • Exome Sequencing
  • RNA Sequencing
  • ETC
Workflow
Consultation
and
Request
Sample
delivery
Sample QC
(Quality Control)
Sequencing
process
Bioinformatics
analysis
Result
delivery
Real-Time PCR (Real-Time Polymerase Chain Reaction)
Analysis Service

Real-Time PCR is a technique used to monitor the amplification of a product in real-time, allowing for the analysis of the amount or genotype of certain nucleic acid sequences. It is widely used in the interpretation of genetic information, such as gene expression analysis or genotype analysis.

Fields of Application
  • Gene Expression
  • SNP genotyping
  • miRNA expression
  • CNV etc.
Workflow
Consultation
and
Request
Sample
delivery
Sample QC
(Quality Control)
Real-time PCR
progress
Result
analysis
Result
delivery

Genomic Analysis
Inquiries

Integrated Sales Headquarters Sales Team 2
+82.2.2027.6267 / +82.2.2027.6283
Go to top